Free Trial

Y Intercept Hong Kong Ltd Invests $1.38 Million in Rubrik, Inc. (NYSE:RBRK)

Rubrik logo with Computer and Technology background

Y Intercept Hong Kong Ltd bought a new stake in Rubrik, Inc. (NYSE:RBRK - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 22,566 shares of the company's stock, valued at approximately $1,376,000.

Several other institutional investors and hedge funds also recently made changes to their positions in RBRK. Russell Investments Group Ltd. purchased a new position in shares of Rubrik in the fourth quarter worth about $28,000. Nemes Rush Group LLC purchased a new position in shares of Rubrik in the fourth quarter worth about $39,000. Point72 Hong Kong Ltd purchased a new position in shares of Rubrik in the fourth quarter worth about $47,000. Quarry LP purchased a new position in shares of Rubrik in the fourth quarter worth about $48,000. Finally, CoreCap Advisors LLC bought a new position in shares of Rubrik in the fourth quarter worth $59,000. Hedge funds and other institutional investors own 49.54% of the company's stock.

Rubrik Stock Performance

Shares of NYSE RBRK traded down $0.63 during mid-day trading on Friday, hitting $85.08. The stock had a trading volume of 2,051,924 shares, compared to its average volume of 3,005,429. Rubrik, Inc. has a 1 year low of $28.60 and a 1 year high of $103.00. The business has a 50 day moving average price of $89.80 and a two-hundred day moving average price of $75.32. The firm has a market cap of $16.46 billion, a P/E ratio of -30.06 and a beta of 0.46.

Rubrik (NYSE:RBRK - Get Free Report) last issued its earnings results on Thursday, June 5th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.32) by $0.17. The firm had revenue of $278.48 million during the quarter, compared to analysts' expectations of $260.39 million. During the same period in the previous year, the firm earned ($1.58) earnings per share. The firm's quarterly revenue was up 48.7% compared to the same quarter last year. Equities research analysts predict that Rubrik, Inc. will post -7.66 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on RBRK. Rosenblatt Securities raised their target price on Rubrik from $82.00 to $110.00 and gave the stock a "buy" rating in a research note on Friday, June 6th. UBS Group reaffirmed a "buy" rating on shares of Rubrik in a report on Friday, June 6th. Roth Capital raised their price target on shares of Rubrik from $97.00 to $107.00 and gave the company a "buy" rating in a report on Friday, June 6th. Wells Fargo & Company upped their price target on shares of Rubrik from $80.00 to $125.00 and gave the stock an "overweight" rating in a report on Friday, June 6th. Finally, Mizuho lowered Rubrik from an "outperform" rating to a "neutral" rating and lifted their price objective for the company from $75.00 to $86.00 in a research note on Thursday, May 15th. Three equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $100.38.

Get Our Latest Stock Analysis on RBRK

Insider Activity

In other Rubrik news, CRO Brian K. Mccarthy sold 25,000 shares of the business's stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $90.10, for a total transaction of $2,252,500.00. Following the transaction, the executive directly owned 504,584 shares of the company's stock, valued at approximately $45,463,018.40. The trade was a 4.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CTO Arvind Nithrakashyap sold 43,128 shares of the business's stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $88.56, for a total transaction of $3,819,415.68. Following the transaction, the chief technology officer directly owned 38,122 shares in the company, valued at approximately $3,376,084.32. The trade was a 53.08% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,233,015 shares of company stock valued at $110,293,527 in the last three months. Corporate insiders own 32.38% of the company's stock.

Rubrik Profile

(Free Report)

Rubrik, Inc provides data security solutions to individuals and businesses worldwide. The company offers enterprise data protection, unstructured data protection, cloud data protection, and SaaS data protection solutions; data threat analytics; data security posture; and cyber recovery solutions. It serves financial, retail, trade, transportation, energy, industrial, healthcare and life science, education, technology, media, communications, and public sectors.

See Also

Institutional Ownership by Quarter for Rubrik (NYSE:RBRK)

Should You Invest $1,000 in Rubrik Right Now?

Before you consider Rubrik, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rubrik wasn't on the list.

While Rubrik currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines